Brain Imaging of Patients with COVID-19: Findings at an Academic Institution during the Height of the Outbreak in New York City

References

1. 1.↵
   1. Oudkerk M,
   2. Büller HR,
   3. Kuijpers D, et al

   . Diagnosis, prevention, and treatment of thromboembolic complications in COVID-19: report of the National Institute for Public Health of the Netherlands. Radiology 2020 Apr 23. [Epub ahead of print] doi:10.1148/radiol.2020201629 pmid:32324101

   CrossRefPubMed
2. 2.
   1. Goyal P,
   2. Choi JJ,
   3. Pinheiro LC, et al

   . Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020;382:2372–74 doi:10.1056/NEJMc2010419 pmid:32302078

   CrossRefPubMed
3. 3.
   1. Zheng YY,
   2. Ma YT,
   3. Zhang JY, et al

   . COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020;17:259–60 doi:10.1038/s41569-020-0360-5 pmid:32139904

   CrossRefPubMed
4. 4.
   1. Klok FA,
   2. Kruip M,
   3. van der Meer NJM, et al

   . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 2020 Apr 10. [Epub ahead of print] doi:10.1016/j.thromres.2020.04.013 pmid:32291094

   CrossRefPubMed
5. 5.↵
   1. Helms J,
   2. Tacquard C,
   3. Severac F

   , et al. CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020;46:1089–98 doi:10.1007/s00134-020-06062-x pmid:32367170

   CrossRefPubMed
6. 6.↵
   1. Fukuhara S,
   2. Rosati CM,
   3. El-Dalati S

   . Acute type A aortic dissection during COVID-19 outbreak. Ann Thorac Surg 2020 Apr 22. [Epub ahead of print] doi:10.1016/j.athoracsur.2020.04.008 pmid:32333849

   CrossRefPubMed
7. 7.↵
   1. Mao L,
   2. Jin H,
   3. Wang M, et al

   . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683. Apr 10. [Epub ahead of print] doi:10.1001/jamaneurol.2020.1127 pmid:32275288

   CrossRefPubMed
8. 8.↵
   1. Wu Y,
   2. Xu X,
   3. Chen Z, et al

   . Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020;87:18–22 doi:10.1016/j.bbi.2020.03.031 pmid:32240762

   CrossRefPubMed
9. 9.↵
   1. Sholle ET,
   2. Kabariti J,
   3. Johnson SB, et al

   . Secondary use of patients' electronic records (SUPER): an approach for meeting specific data needs of clinical and translational researchers. AMIA Annu Symp Proc 2017;2017:1581–88 pmid:29854228

   PubMed
10. 10.↵
    1. Schweitzer AD,
    2. Parikh NS,
    3. Askin G, et al

    . Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome. Neuroradiology 2017;59:379–86 doi:10.1007/s00234-017-1815-1 pmid:28289809

    CrossRefPubMed
11. 11.↵
    1. Poyiadji N,
    2. Shahin G,
    3. Noujaim D, et al

    . COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology 2020;296:E119–20 doi:10.1148/radiol.2020201187 pmid:32228363

    CrossRefPubMed
12. 12.↵
    1. Helms J,
    2. Kremer S,
    3. Merdji H, et al

    . Neurologic features in severe SARS-CoV-2 infection. N Engl J Med 2020;382:2268–70 doi:10.1056/NEJMc2008597 pmid:32294339

    CrossRefPubMed
13. 13.↵
    1. Kandemirli SG,
    2. Doagn L,
    3. Sarikaya ZT, et al

    . Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology 2020 May 8. [Epub ahead of print] doi:10.1148/radiol.2020201697 10.1148/radiol.2020201697 pmid:32384020

    CrossRefPubMed
14. 14.↵
    1. Lantos JE,
    2. Strauss SB,
    3. Lin E

    . COVID-19 associated Miller Fisher syndrome: MRI findings. AJNR Am J Neuroradiol 2020;41:1184–86 doi:10.3174/ajnr.A6609 pmid:32467190

    Abstract/FREE Full Text
15. 15.↵
    1. Eliezer M,
    2. Hautefort C,
    3. Hamel A, et al

    . Sudden and complete olfactory loss function as a possible symptom of COVID-19. JAMA Otolaryngol Head Neck Surg 2020 Apr 8. [Epub ahead of print] doi:10.1001/jamaoto.2020.0832 pmid:32267483

    CrossRefPubMed
16. 16.↵
    1. Adams HP,
    2. Bendixen BH,
    3. Kappelle LJ, et al

    . Classification of subtype of acute ischemic stroke; definitions for use in a multicenter clinical trial—TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41 doi:10.1161/01.str.24.1.35 pmid:7678184

    Abstract/FREE Full Text
17. 17.↵
    1. Hart RG,
    2. Diener HC,
    3. Connolly SJ

    . Embolic strokes of undetermined source: support for a new clinical construct—authors’ reply. Lancet Neurol 2014;13:967 doi:10.1016/S1474-4422(14)70197-8 pmid:25231516

    CrossRefPubMed
18. 18.↵
    1. Meretoja A,
    2. Strbian D,
    3. Putaala J, et al

    . SMASH-U: a proposal for etiologic classification of intracerebral hemorrhage. Stroke 2012;43:2592–97 doi:10.1161/STROKEAHA.112.661603 pmid:22858729

    Abstract/FREE Full Text
19. 19.↵
    1. Riech S,
    2. Kallenberg K,
    3. Moerer O, et al

    . The pattern of brain microhemorrhages after severe lung failure resembles the one seen in high-altitude cerebral edema. Crit Care Med 2015;43:e386–89 doi:10.1097/CCM.0000000000001150 pmid:26110491

    CrossRefPubMed
20. 20.↵
    1. Fanou EM,
    2. Coutinho JM,
    3. Shannon P, et al

    . Critical-illness associated cerebral microbleeds. Stroke 2017;48:1085–87 doi:10.1161/STROKEAHA.116.016289 pmid:28235962

    Abstract/FREE Full Text
21. 21.↵
    1. Vaira LA,
    2. Salzano G,
    3. Deiana G, et al

    . Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope 2020;130:1787doi:10.1002/lary.28692 pmid:32237238

    CrossRefPubMed
22. 22.↵
    1. Gane SB,
    2. Kelly C,
    3. Hopkins C

    . Isolated sudden onset anosmia in COVID-19 infection: a novel syndrome? Rhinology 2020;58:299–301 doi:10.4193/Rhin20.114 pmid:32240279

    CrossRefPubMed
23. 23.↵
    1. Hopkins C,
    2. Surda P,
    3. Kumar BN

    . Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology 2020;58:295–98 doi:10.4193/Rhin20.116 pmid:32277751

    CrossRefPubMed
24. 24.↵
    1. Mahammedi A,
    2. Saba L,
    3. Vagal A, et al

    . Imaging in neurological disease of hospitalized COVID-19 patients: an Italian multicenter retrospective observational study. Radiology 2020 May 21. [Epub ahead of print] doi:10.1148/radiol.2020201933 pmid:32437313

    CrossRefPubMed
25. 25.↵
    1. Becker RC

    . COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 2020;50:54–67 doi:10.1007/s11239-020-02134-3 pmid:32415579

    CrossRefPubMed
26. 26.↵
    1. Zhang Y,
    2. Xiao M,
    3. Zhang S, et al

    . Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020;382:e38 doi:10.1056/NEJMc2007575 pmid:32268022

    CrossRefPubMed
27. 27.↵
    1. Tang N,
    2. Li D,
    3. Wang X, et al

    . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020;18:844–47 doi:10.1111/jth.14768 pmid:32073213

    CrossRefPubMed
28. 28.↵
    1. Franceschi AM,
    2. Ahmed O,
    3. Giliberto L, et al

    . Hemorrhagic posterior reversible encephalopathy syndrome as a manifestation of COVID-19 infection. AJNR Am J Neuroradiol 2020;41:1173–76 doi:10.3174/ajnr.A6595 pmid:32439646

    Abstract/FREE Full Text
29. 29.↵
    1. Radmanesh A,
    2. Derman A,
    3. Liu YW, et al

    . COVID-19-associated diffuse leukoencephalopathy and microhemorrhages. Radiology 2020 May 21. [Epub ahead of print] doi:10.1148/radiol.2020202040 pmid:32437314

    CrossRefPubMed
30. 30.↵
    1. Kallenberg K,
    2. Dehnert C,
    3. Dörfler A, et al

    . Microhemorrhages in nonfatal high-altitude cerebral edema. J Cereb Blood Flow Metab 2008;28:1635–42 doi:10.1038/jcbfm.2008.55 pmid:18523438

    CrossRefPubMed
31. 31.↵
    1. Shah J,
    2. Armstrong MJ

    . Extracorporeal membrane oxygenation: uncommon cause of corpus callosal microhemorrhage. Neurology 2015;84:630 doi:10.1212/WNL.0000000000001227 pmid:25666630

    Abstract/FREE Full Text
32. 32.↵
    1. Toscano G,
    2. Palmerini F,
    3. Ravaglia S, et al

    . Guillain–Barré syndrome associated with SARS-CoV-2. N Engl J Med 2020;382:2574–76 doi:10.1056/NEJMc2009191 pmid:32302082

    CrossRefPubMed
33. 33.↵
    1. Parra B,
    2. Lizarazo J,
    3. Jiménez-Arango JA, et al

    . Guillain-Barré syndrome associated with Zika virus infection in Colombia. N Engl J Med 2016;375:1513–23 doi:10.1056/NEJMoa1605564 pmid:27705091

    CrossRefPubMed
34. 34.↵
    1. Brasil P,
    2. Sequeira PC,
    3. Freitas AD, et al

    . Guillain-Barré syndrome associated with Zika virus infection. Lancet 2016;387:1482 doi:10.1016/S0140-6736(16)30058-7 pmid:27115821

    CrossRefPubMed
35. 35.↵
    1. Zhao H,
    2. Shen D,
    3. Zhou H, et al

    . Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 2020;19:383–84 doi:10.1016/S1474-4422(20)30109-5 pmid:32246917

    CrossRefPubMed
36. 36.↵
    1. Bilinska K,
    2. Jakubowska P,
    3. Von Bartheld CS, et al

    . Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in cells of the olfactory epithelium: identification of cell types and trends with age. ACS Chem Neurosci 2020;11:1555–62 doi:10.1021/acschemneuro.0c00210 pmid:32379417

    CrossRefPubMed
37. 37.↵
    1. Li Y,
    2. Bai W,
    3. Hashikawa T

    . The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. J Med Virol 2020;92:552–55 doi:10.1002/jmv.25728 pmid:32104915

    CrossRefPubMed
38. 38.↵
    1. Netland J,
    2. Meyerholz DK,
    3. Moore S, et al

    . Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008;82:7264–75 doi:10.1128/JVI.00737-08 pmid:18495771

    Abstract/FREE Full Text
39. 39.↵
    1. Li K,
    2. Wohlford-Lenane C,
    3. Perlman S, et al

    . Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis 2016;213:712–22 doi:10.1093/infdis/jiv499 pmid:26486634

    CrossRefPubMed
40. 40.↵
    1. Varga Z,
    2. Flammer AJ,
    3. Steiger P, et al

    . Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020;395:1417–18 doi:10.1016/S0140-6736(20)30937-5 pmid:32325026

    CrossRefPubMed